Daniel Joseph OConnell sold $88k of ABOS
Chief Executive Officer at Acumen Pharmaceuticals, Inc.. 47,778 shares at an average of $1.84, traded Jan 3, 2025, filed Jan 7, 2025.
Score components
- +25RoleCEO
- +9Trade size$88k at market
- 0Share of holdings soldSold 9.5% of holdings
- +15Cluster5 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001576885-25-000021, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 3, 2025 | SOpen-market sale Common Stock10b5-1 | -47,778 | $1.84 | $88k | 454,707 | Jan 7, 2025 |
| Jan 7, 2025 | AGrant or award Common Stock10b5-1 | +225,400 | $0.00 | $0 | 680,107 | Jan 7, 2025 |
| Jan 7, 2025 | AGrant or award Employee Stock Option (right to buy)derivative10b5-1 | +338,000 | $0.00 | $0 | 338,000 | Jan 7, 2025 |
Related signals
Other insiders at Acumen Pharmaceuticals, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | Acumen Pharmaceuticals, Inc. | Eric Siemers Chief Medical Officer | $5,118 3,219 shares | -2% | |
| 15Weak | Acumen Pharmaceuticals, Inc. | Russell Barton Chief Operating Officer | $4,692 2,914 shares | -2% | |
| 10Weak | Acumen Pharmaceuticals, Inc. | Derek M Meisner Chief Legal Officer & Corp Sec | $5,435 3,418 shares | -2% | |
| 20Weak | Acumen Pharmaceuticals, Inc. | Daniel Joseph OConnell Chief Executive Officer | $20k 12,619 shares | -2% | |
| 29Weak | Acumen Pharmaceuticals, Inc. | Matt Zuga CFO & Chief Business Officer | $57k 33,266 shares | -13% | |
| 10Weak | Acumen Pharmaceuticals, Inc. | Eric Siemers Chief Medical Officer | $20k 10,859 shares | -9% | |
| 17Weak | Acumen Pharmaceuticals, Inc. | Matt Zuga CFO & Chief Business Officer | $24k 13,235 shares | -6% | |
| 15Weak | Acumen Pharmaceuticals, Inc. | Russell Barton Chief Operating Officer | $14k 7,636 shares | -8% | |
| 15Weak | Acumen Pharmaceuticals, Inc. | Derek M Meisner Chief Legal Officer & Corp Sec | $21k 11,122 shares | -10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.